Pharmacological Reviews

Pharmacological Reviews. It is a premier peer-reviewed medical journal that publishes comprehensive review articles on significant topics across the broad spectrum of pharmacological sciences. Established in 1949, the journal is published by the American Society for Pharmacology and Experimental Therapeutics and serves as a critical resource for researchers, clinicians, and educators. Its articles synthesize vast bodies of research, providing authoritative insights into drug action, therapeutic mechanisms, and emerging trends in biomedicine.

History and Development

The journal was founded in 1949 under the editorial leadership of John C. McGiff, emerging during a period of rapid expansion in biomedical research following World War II. Its creation was driven by the American Society for Pharmacology and Experimental Therapeutics to meet the growing need for authoritative syntheses of the burgeoning literature in drug discovery and molecular pharmacology. Over the decades, it has evolved from publishing traditional narrative reviews to incorporating systematic reviews and perspectives on cutting-edge methodologies, reflecting shifts in the field influenced by the Human Genome Project and advances in structural biology. The journal's publication was historically associated with the Williams & Wilkins company before moving to its current publisher.

Scope and Content

The journal's scope encompasses the entire field of pharmacology and its interfaces with related disciplines. Typical content includes in-depth reviews on G protein-coupled receptor signaling, cytochrome P450 metabolism, pharmacogenomics, neuropharmacology, cardiovascular pharmacology, and cancer chemotherapy. It regularly features articles on the mechanisms of action of major drug classes, such as opioids, statins, and monoclonal antibodies, as well as explorations of emerging therapeutic targets like CRISPR-based therapies and RNA interference. The content is designed to be accessible yet rigorous, bridging foundational concepts from classical pharmacology with modern insights from systems biology and computational chemistry.

Editorial Process and Impact

The editorial process is overseen by an appointed Editor-in-Chief and a distinguished international editorial board comprising leading scientists from institutions like the National Institutes of Health, Harvard Medical School, and the University of Cambridge. Manuscripts undergo a rigorous single-blind peer review process involving experts in specific sub-disciplines to ensure scholarly accuracy and clinical relevance. The journal maintains a high impact factor, consistently ranking among the top journals in the Pharmacology & Pharmacy category of the Journal Citation Reports. Its articles are frequently cited in major textbooks, clinical guidelines from organizations like the Food and Drug Administration, and foundational papers in journals such as Nature Reviews Drug Discovery and Annual Review of Pharmacology and Toxicology.

Notable Articles and Contributions

The journal has published numerous seminal reviews that have shaped pharmacological thought and practice. Early influential works included comprehensive treatises on autonomic nervous system pharmacology and the mechanisms of diuretic agents. Landmark later articles have covered the nitric oxide signaling pathway, the role of tumor necrosis factor in inflammation, and the pharmacology of immune checkpoint inhibitors. These publications often serve as definitive reference works, cited in key clinical trials and regulatory documents. The journal has also featured thematic series on critical topics, such as the pharmacology of SARS-CoV-2 and the opioid crisis, contributing directly to public health dialogues.

Relationship to Professional Societies

The journal is an official publication of the American Society for Pharmacology and Experimental Therapeutics, a founding member society of the Federation of American Societies for Experimental Biology. This relationship ensures its content aligns with the society's mission to advance the science of pharmacology and mentor future scientists. The editorial leadership often includes past presidents of the society, such as Raymond L. Woosley and Michael J. Kuhar. The journal collaborates closely with other society initiatives, including the annual meeting of the American Society for Pharmacology and Experimental Therapeutics and educational programs, reinforcing its role as a cornerstone of the society's scholarly output and a vital link between academic research, the pharmaceutical industry, and regulatory science. Category:Pharmacology journals Category:American Society for Pharmacology and Experimental Therapeutics Category:Quarterly journals Category:English-language journals Category:Publications established in 1949